InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,477.42
(
-0.01%
)
US TECH 100
19,240.42
(
0.13%
)
Dow Jones
39,179.50
(
0.13%
)
Brent Oil
85.14
(
0.79%
)
Bitcoin
61,789.65
(
1.61%
)
Post# of 252399
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 833
Posts 119931
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: genisi post# 96920

Tuesday, 06/08/2010 9:35:16 AM

Tuesday, June 08, 2010 9:35:16 AM

Post# of 252399

I assume Teva will switch patients and then withdraw the old product [regular Copaxone] from the market.

To my knowledge, this wouldn’t prevent docs from writing a script for regular Copaxone and having it filled by the generic. I’m pretty sure there are others cases where a branded product was withdrawn and its generics continued to be sold.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up